Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Valérie Eschwege"'
Autor:
Caroline Laroye, Nathalie Thilly, M. Gauthier, Amandine Luc, Véronique Latger-Cannard, Valérie Eschwege, Danièle Bensoussan, Cécile Pochon, Arnaud Campidelli, Marie-Thérèse Rubio, Maud D'Aveni, Véronique Decot
Publikováno v:
Cytotherapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b12ef8c72d62645e20f68fd1b45f2e1
https://doi.org/10.1016/j.jcyt.2023.04.006
https://doi.org/10.1016/j.jcyt.2023.04.006
Autor:
Alain Stépanian, Florence Fischer, Claire Flaujac, Valérie Eschwège, Céline Delassasseigne, Léna Leflem, Frédéric Loridon, Sophie Voisin, Dominique Lasne
Publikováno v:
Platelets, Vol 35, Iss 1 (2024)
Light transmission aggregometry (LTA) is a method used to investigate platelet functions in platelet-rich plasma (PRP), notably when screening for platelet disorders. Various national guidelines and recommendations help in setting up the LTA test in
Externí odkaz:
https://doaj.org/article/4282997560ad40999a37a63f6f7e67f1
Autor:
Emmanuelle, Jeanpierre, Claire, Pouplard, Dominique, Lasne, Véronique, Le Cam Duchez, Valérie, Eschwege, Claire, Flaujac, Hubert, Galinat, Ines, Harzallah, Valérie, Proulle, Motalib, Smahi, Frédéric, Sobas, Nataliia, Stepina, Pierre, Toulon, Sophie, Voisin, Catherine, Ternisien, Christophe, Nougier, Annelise, Voyer
Publikováno v:
European Journal of Haematology. 105:103-115
Replacement therapy with plasma-derived or recombinant FVIII and FIX (pdFVIII/pdFIX or rFVIII/rFIX) concentrates is the standard of treatment in patients with haemophilia A and B, respectively. Measurement of factor VIII (FVIII:C) or factor IX (FIX:C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afb730430e2746a5daf5c26e6a467f90
https://doi.org/10.1111/ejh.13423
https://doi.org/10.1111/ejh.13423
Autor:
Claire, Pouplard, Emmanuelle, Jeanpierre, Dominique, Lasne, Véronique, Le Cam Duchez, Valérie, Eschwege, Claire, Flaujac, Hubert, Galinat, Ines, Harzallah, Valérie, Proulle, Motalib, Smahi, Frédéric, Sobas, Catherine, Ternisien, Pierre, Toulon, Sophie, Voisin, Christophe, Nougier, Annelise, Voyer
Publikováno v:
Annales de Biologie Clinique
Annales de Biologie Clinique, John Libbey Eurotext, 2019, 77 (1), pp.41-52. ⟨10.1684/abc.2019.1414⟩
Annales de Biologie Clinique, 2019, 77 (1), pp.41-52. ⟨10.1684/abc.2019.1414⟩
Annales de Biologie Clinique, John Libbey Eurotext, 2019, 77 (1), pp.41-52. ⟨10.1684/abc.2019.1414⟩
Annales de Biologie Clinique, 2019, 77 (1), pp.41-52. ⟨10.1684/abc.2019.1414⟩
International audience; Replacement therapy with plasma-derived or recombinant FIX (pdFIX or rFIX) concentrates is the standard of treatment in patients with hemophilia B. The method predominantly used for measuring factor IX (FIX:C) levels is the on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94d12f2b9840d273fe2183cc78d562ca
https://hal.umontpellier.fr/hal-02884994
https://hal.umontpellier.fr/hal-02884994
Autor:
Véronique Regnault, Valérie Eschwege, Christine Perret-Guillaume, D. Wahl, Christine Selton-Suty, P. Dotto, J.-F. Bruntz, E. Bode-Dotto, Stéphane Zuily, E de Maistre, T. Lecompte
Publikováno v:
Circulation. 124:215-224
Background— Heart valve disease (HVD) is frequent in patients with systemic lupus erythematosus (SLE), and the role of antiphospholipid antibodies (aPL) is controversial. Thus, our objective was to estimate the risk of HVD, including Libman-Sacks e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca7a1a123eb660cb202bba1d94148739
https://doi.org/10.1161/circulationaha.111.028522
https://doi.org/10.1161/circulationaha.111.028522
Autor:
Jean Szymezak, Claire Flaujac, Claire Pouplard, Hubert Galinat, Catherine Ternisien, François Grand, Yohann Repessé, Laurent Sattler, Emmanuel de Maistre, Valérie Eschwege, Emmanuelle Jeanpierre, Anne Ryman, Magali Donnard
Publikováno v:
Blood. 132:1196-1196
Background: The use of extending half-life (EHL) FVIII or FIX products is today a current strategy in Hemophilia A (HA) patients for improving prophylaxis and reducing the number of IV injections. Fc fusion technology is based on the use of the neona
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e362d34187f534b3d7bba0d39295d0b
https://doi.org/10.1182/blood-2018-99-110036
https://doi.org/10.1182/blood-2018-99-110036
Autor:
Celine Desconclois, Valérie Proulle, Marie Dreyfus, Tewfik Boutekedjiret, Valérie Eschwege, Pierre Toulon
Publikováno v:
Thrombosis research. 134(5)
The “so-called” pediatric tubes are often used when collecting smaller blood volume is necessary, particularly in pediatric patients or in case of difficult/recurrent sampling. The aim of this multicenter study was to compare coagulation test res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5545741bf77865c4da09d1067353d9d7
https://pubmed.ncbi.nlm.nih.gov/25248688
https://pubmed.ncbi.nlm.nih.gov/25248688
Autor:
Doruk Erkan, Véronique Regnault, Evelyn M. Horn, Denis Wahl, Stéphane Zuily, C. Suty-selton, Vinicius Domingues, Valérie Eschwege
Publikováno v:
Journal des Maladies Vasculaires. 40:314
Objectifs L’hypertension pulmonaire (HTP) est decrite chez les patients presentant un lupus erythemateux systemique (LES). Cependant, l’impact des anticorps antiphospholipides (aPL) est controverse. Ainsi, notre objectif etait d’effectuer une m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4ef4be4db272c87f122a464ce6ca04f
https://doi.org/10.1016/j.jmv.2015.07.043
https://doi.org/10.1016/j.jmv.2015.07.043
Publikováno v:
Infectious Diseases in Obstetrics and Gynecology, Vol 5, Iss 2, Pp 176-180 (1997)
Antiphospholipid antibodies (APA) are associated with thrombosis, thrombocytopenia and fetal loss but they occur in a variety of diseases. Despite many efforts, a correlation between the specificity of particular subgroups of APA and particular clini
Externí odkaz:
https://doaj.org/article/586716c7ce5246168da0073b4e42d2bd